PermanenteDocs Chat podcast on flu, COVID, and RSV vaccine safety and effectiveness updates with Sandra Fryhofer, MD, of the American Medical Association.
Helping the media provide up-to-date information surrounding the coronavirus pandemic, our Permanente physician experts provide evidence-based medicine to ease fears.
A study published in the New England Journal of Medicine, led by Lisa A. Jackson, MD, of Kaiser Permanente’s Washington Health Research Institute, reports on promising results in the phase 1 trial of an experimental COVID-19 vaccine.
Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.
Stephen Parodi, MD, an associate executive director of The Permanente Medical Group in Northern California, told Voice of America that Kaiser Permanente is working with “light speed” to build a new 7,000-square-foot testing lab in Berkeley.
Over the last several weeks, an outpouring of gratitude and support for those working tirelessly on the front lines to combat COVID-19 has filled social media.
Evidence is mounting that California may have temporarily relieved pressure on hospitals by issuing the first statewide stay-at-home order in the United States, according to this CBC News report.
As the coronavirus pandemic grows and the number of cases quickly rises in the United States, the 63-page Kaiser Permanente Northern California COVID-19 Hospital Surge Playbook includes detailed guidance for ICU expansion and management.
As more health systems embrace telemedicine during the COVID-19 pandemic, The Permanente Federation Chief Information Officer Ed Lee, MD, explained that Kaiser Permanente is using telehealth as a default for most visits
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.